Search clinical trials for: Salbutamol

Total 470 results

Intech Biopharm Ltd.

Completed

Efficacy Study of SYN006 HFA MDI in Asthma Patients

Asthma

Taiwan
Teva Branded Pharmaceutical Products R&D, Inc.

Terminated

A Twelve Month Long Term Safety Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler With Both Repeated and as Needed Dosing

Asthma

United States
Radboud University Medical Center

Completed

The Effect of Antecedent Hypoglycaemia on β2-adrenergic Sensitivity

Diabetes | Hypoglycemia Unawareness

Netherlands
Nemours Children's Clinic

Completed

Dose-response of Albuterol in Asthmatics

Asthma

United States
Novartis Pharmaceuticals

Withdrawn

Study of Efficacy and Safety of NVA237 in Patients With Poorly Controlled Asthma

Asthma
Ohio State University

Completed

Randomized Study of Albuterol in Patients With Facioscapulohumeral Muscular Dystrophy

Muscular Dystrophy, Facioscapulohumeral
FDA Office of Orphan Products Development

Completed

Study of Albuterol and Oxandrolone in Patients With Facioscapulohumeral Dystrophy (FSHD)

Muscular Dystrophies

United States
Novartis Pharmaceuticals

Completed

Efficacy of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) (FAST)

Chronic Obstructive Pulmonary Disease

Germany
Prof. Dominique de Quervain, MD
Clinical Trial Unit, University Hospital Basel, Switzerland

Completed

Influence of Salbutamol on Emotional and Cognitive Functions in Healthy Subjects (Salmon-Basel)

Memory Functions

Switzerland
University Hospitals Cleveland Medical Center

Withdrawn

Steroids Helping Albuterol Responders Exclusively (SHARE)

Bronchiolitis

United States
Sture Andersson

Unknown

Inhaled Salbutamol in Elective Caesarean Section (SAISTY)

Cesarean Section | Postnatal Pulmonary Adaptation

Finland
Duke University

Completed

Quantifying the Presence of Lung Disease and Pulmonary Hypertension in Children With Sickle Cell Disease

Sickle Cell Disease

United States
Royal Brompton & Harefield NHS Foundation Trust
GlaxoSmithKline

Completed

IPF Drug Deposition Study (TOPICAL-IPF)

Idiopathic Pulmonary Fibrosis

United Kingdom
Boehringer Ingelheim

Completed

Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive

United States
University of Florida
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Dose-Response of Salmeterol in Children

Asthma

United States
Boehringer Ingelheim

Terminated

Study to Assess the Efficacy of Ipratropium Bromide Associated With High Dose Salbutamol by Repeated Nebulisation Versus Repeat Nebulisation of Salbutamol Alone, in Acute Asthmatic Attacks in Young Children

Asthma
Beijing Chao Yang Hospital
First Affiliated Hospital of Chongqing Medical University

Unknown

Bronchodilator Test in Mechanical Ventilated Chronic Obstructive Pulmonary Disease Patients

Chronic Obstructive Pulmonary Disease

China
Duke University

Completed

Aerosolized Beta-Agonist Isomers in Asthma

Asthma
Sunovion

Completed

A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma

Asthma

United States
Hôpital Necker-Enfants Malades

Completed

Pharmacogenetic of Salbutamol in Pediatric Asthma Crisis (Pegase)

Asthma

France
Boehringer Ingelheim

Completed

Ipratropium or Salbutamol Sulphate Alone or Combination Therapy Salbutamol and Ipratropium in Patients With COPD

Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim

Completed

Combivent vs. Salbutamol in Patients With Metacholine Induced Bronchospasm

Asthma
Boehringer Ingelheim

Terminated

Efficacy and Safety of Combivent® Aerosol and Spacer, in Adult Patients With Moderate to Severe Asthma Crisis

Asthma
Boehringer Ingelheim

Completed

Ipratropium Bromide/Salbutamol Delivered by the Respimat® Inhaler Compared to Ipratropium Bromide Respimat®, COMBIVENT® Inhalation Aerosol and Placebo in Adults With Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim

Completed

A Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent Inhalation Aerosol in COPD Patients.

Pulmonary Disease, Chronic Obstructive

United States
Novartis Pharmaceuticals

Completed

Efficacy, Safety, and Tolerability of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) (GLOW5)

Chronic Obstructive Pulmonary Disease

Germany, India, South Africa, Croatia, Estonia, Poland, Lithuania, Guatemala, Czech Republic, France, Philippines, Korea, Republic of, Taiwan, Canada, Latvia
Liaoning University of Traditional Chinese Medicine
Beijing University of Chinese Medicine

Completed

Effectiveness Study of Integrative Treatment for Pediatric Pneumonia

Pneumonia

China
Boehringer Ingelheim

Completed

4 Week 2 Way Crossover Double Blind Treatment Phase With Combivent CFC Versus Albuterol Followed by a 4 Week Open Label Combivent Respimat When All Drugs Are Used for Symptom Relief as Needed in Pts With Moderate to Severe Asthma

Asthma

United States
Novartis Pharmaceuticals

Completed

The Effect of QVA149 on Patient Reported Dyspnea in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (BLAZE)

Chronic Obstructive Pulmonary Disease

Germany, Belgium, Spain, Canada, United Kingdom
University of Rome Tor Vergata

Unknown

Bronchoreversibility and Radiologic Morphology of Emphysema

Emphysema | COPD

Italy
Novartis Pharmaceuticals

Completed

Effect of QVA149 Versus NVA237 and Tiotropium on Chronic Obstructive Pulmonary Disorder (COPD) Exacerbations (SPARK)

Chronic Obstructive Pulmonary Disease

Germany, United States, Colombia, Poland, South Africa, Canada, Estonia, Hungary, India, Austria, Israel, Netherlands, United Kingdom, Argentina, France, Italy, Spain, Czech Republic, Denmark, Finland, Greece, Ireland, Mexico, Peru, Phi... and more
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Pharmacokinetic and Pharmacodynamic Profiles of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients With Asthma

Asthma

United States
Boehringer Ingelheim

Completed

Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma

Asthma

United States
Boehringer Ingelheim

Completed

A Comparison of Combivent UDV (Ipratropium 500mcg and Salbutamol 2.5mg) and Salbutamol UDV Alone (2.5mg)

Asthma

Philippines
University of California, San Francisco

Withdrawn

Nebulized Albuterol for Congestive Heart Failure Exacerbation (ACHE)

Congestive Heart Failure

United States
Imperial College London
GlaxoSmithKline

Terminated

Assessment of Ventilation-perfusion Abnormalities in Patients With Stable Smoking-related Airways Disease

Chronic Obstructive Pulmonary Disease

United Kingdom
Laval University
Université de Montréal

Unknown

Sensitivity of the Step Test to Detect Improvement in Dyspnea Following Bronchodilation in Patients With Chronic Obstructive Pulmonary Disease (CODEx)

Dyspnea | Severe Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary Disease

Canada
Dr.Vandana Bansal

Unknown

Effects of Aspirin and Low Molecular Weight Heparin in IVF Outcome.

To Investigate the Effects of Low Dose Aspirin and Low Molecular Weight Heparin in IVF Out Come

India
Amphastar Pharmaceuticals, Inc.

Terminated

4-Week Study of Efficacy, Safety and PK of Albuterol-HFA Versus Proventil-HFA in Pediatric Asthma

Asthma

United States
Amphastar Pharmaceuticals, Inc.

Terminated

Controlled, 12-Week Study of Albuterol HFA Versus the Active Control, Proventil(R)-HFA in Asthmatic Patients

Asthma

United States
Amphastar Pharmaceuticals, Inc.

Terminated

Single-Dose Cross-Over Study of the Effects of Albuterol-HFA in Exercise Induced Bronchoconstriction

Asthma | Bronchospasm

United States
Chongqing Medical University

Completed

Lung Function of Asthmatic Children by Nebulized MgSO4

Asthma

China
Chongqing Medical University

Completed

Lung Function Changes of Induced Asthma Children Treated With Inhaled MgSO4

Asthma

China
Laval University

Completed

Role of Airway Hyperresponsiveness on Performance in Elite Swimmers.

Asthma

Canada
Henan University of Traditional Chinese Medicine

Unknown

A Randomized Comparative Effectiveness Research Trial of Three Treatments for COPD Patients

Pulmonary Disease, Chronic Obstructive

China
Children's Hospital of Philadelphia
Sunovion

Completed

Continuous Levalbuterol for Treatment of Status Asthmaticus in Children

Asthma

United States
Marquette University

Completed

Equivalence of a Human-Powered Nebulizer to an Electric Nebulizer

Asthma

El Salvador
IRCCS Azienda Ospedaliera Universitaria San Martino...

Completed

Respiratory Impedance and Obliterative Bronchiolitis (FOT-BOS)

Hematopoietic Stem Cell Transplantation | Obliterative Bronchiolitis

Italy
AstraZeneca

Completed

To Investigate the Relative Efficacy of Terbutaline Turbuhaler® and Salbutamol Pressurized Metered Dose Inhaler (pMDI) a Single Blind Study

Asthma

Japan
Children's Hospital of Philadelphia

Completed

Budesonide Inhalation Suspension for Acute Asthma in Children

Asthma | Acute Asthma | Reactive Airway Exacerbation

United States

3

Subscribe